The ILT gene family includes up to 11 members in the human. The extracellular portion of all members includes at least two and usually four immuno-globulin domains. ILT-2 through 5 are all inhibitory members having variable numbers of cytoplasmic ITIM domains. ILT family proteins are expressed predominantly on myeloid lineage cells, and some members have been shown to bind classical (HLA-A and -B) and non-classical (HLA-G1, -E and -F) MHC class I molecules. Several nomenclatures exist, giving each member a different ILT, LIR, LILR, CD85 or other designation.
Human LILRA3/CD85e (NP_006856) VersaClone cDNA
R&D Systems | Catalog # RDC1275
Loading...
Loading...
Formulation, Preparation, and Storage
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Background: LILRA3/CD85e
Long Name
Leukocyte Immunoglobulin-like Receptor, Subfamily A (with TM and ITIM Domains), Member 3
Alternate Names
CD85e, HM31, HM43, ILT6, LIR4
Entrez Gene IDs
11026 (Human)
Gene Symbol
LILRA3
UniProt
Additional LILRA3/CD85e Products
Product Documents for Human LILRA3/CD85e (NP_006856) VersaClone cDNA
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human LILRA3/CD85e (NP_006856) VersaClone cDNA
For research use only
Customer Reviews for Human LILRA3/CD85e (NP_006856) VersaClone cDNA
There are currently no reviews for this product. Be the first to review Human LILRA3/CD85e (NP_006856) VersaClone cDNA and earn rewards!
Have you used Human LILRA3/CD85e (NP_006856) VersaClone cDNA?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Loading...